Add BrightSurf on Google Email

The Lancet


The Lancet: New triple antiviral drug combination shows early promise for treating COVID-19 in phase 2 randomized trial

A two-week course of antiviral therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin has been found to be safe and more effective at reducing the duration of viral shedding than lopinavir-ritonavir alone in patients with mild to moderate COVID-19. The treatment combination also showed significant shortening of hospital...

SourceThe Lancet·JournalThe Lancet·DateMay 8, 2020

The Lancet Rheumatology: Small observational study of patients with severe COVID-19 treated with the arthritis drug anakinra finds clinical improvements

A small observational study of 29 Italian patients with severe COVID-19 and hyperinflammation found that high-dose intravenous anakinra was associated with respiratory improvements and reduced signs of cytokine storm in 72% of patients. The treatment was generally safe, but more research is needed to fully understand its effectiveness.

SourceThe Lancet·JournalThe Lancet Rheumatology·DateMay 7, 2020

The Lancet: First randomized trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits, more research needed

A randomized trial of remdesivir suggests the antiviral drug is not associated with significant clinical benefits for treating COVID-19. Patients treated with remdesivir within 10 days of symptom onset showed faster recovery compared to those given placebo, but results were not statistically significant.

SourceThe Lancet·JournalThe Lancet·DateApr 29, 2020

The Lancet Public Health: Study examines how Hong Kong managed first wave of COVID-19 without resorting to complete lockdown

A study published in The Lancet Public Health found that Hong Kong successfully controlled the first wave of COVID-19 without resorting to a complete lockdown. By implementing measures such as border entry restrictions, quarantine, isolation, and social distancing, the city was able to contain the outbreak and reduce transmission rates.

SourceThe Lancet·JournalThe Lancet Public Health·DateApr 17, 2020

The Lancet Gasteroenterology & Hepatology: First clinical trial finds probiotic treatment with dead bacteria is better than placebo at alleviating symptoms of irritable bowel syndrome

A new 12-week clinical trial found that heat-inactivated Bifidobacterium bifidum MIMBb75 improved IBS symptoms by at least 30% in 34% of patients compared to 19% on placebo. The treatment was also associated with a strong placebo effect, but the dead bacterial cells were still significantly better than placebo.

SourceThe Lancet·JournalThe Lancet Gastroenterology & Hepatology·DateApr 8, 2020

The Lancet: Modelling study estimates impact of relaxing control measures on possible second wave of COVID-19 in China

A modelling study suggests that relaxing control measures in regions outside Hubei province could lead to a second wave of COVID-19 infection, with cases potentially exceeding 1 and resulting in higher health and economic loss. The study advises policymakers to fine-tune control measures using real-time monitoring of transmissibility a...

SourceThe Lancet·JournalThe Lancet·DateApr 8, 2020

The Lancet Public Health: US modelling study estimates impact of school closures for COVID-19 on US health-care workforce and associated mortality

A new modelling study published in The Lancet Public Health finds that school closures to reduce COVID-19 transmission may lead to increased childcare needs among healthcare workers, potentially compromising the system's response. Researchers estimate that up to 15% of health-care workers may need additional childcare, with certain occ...

SourceThe Lancet·JournalThe Lancet Public Health·DateApr 3, 2020

The Lancet Public Health: Modelling study estimates impact of physical distancing measures on progression of COVID-19 epidemic in Wuhan

Researchers estimate that extending school and workplace closures in Wuhan until April would delay a second wave of cases until later in the year, relieving pressure on health services. Physical distancing measures are likely to be most effective if staggered return to work commences at the beginning of April.

SourceThe Lancet·JournalThe Lancet Public Health·DateMar 25, 2020

The Lancet Infectious Diseases: Singapore modelling study estimates impact of physical distancing on reducing spread of COVID-19

A Singapore modelling study suggests that quarantining infected individuals and their families, school closures, and workplace distancing are effective in reducing COVID-19 cases. The combined approach was found to be most effective, preventing a national outbreak at relatively low levels of infectivity.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateMar 24, 2020

The Lancet Public Health: Access to identification documents reflecting gender identity may improve trans mental health

A study of over 20,000 American trans adults found that having access to identification documents reflecting their identified gender is associated with reduced psychological distress and lower rates of suicidal thoughts. The authors suggest policy changes to increase access to gender-concordant IDs, including reducing fees and administ...

SourceThe Lancet·JournalThe Lancet Public Health·DateMar 16, 2020

The Lancet HIV: Study suggests a second patient has been cured of HIV

A study of a second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy. The patient had a healthy CD4 cell count, suggesting they have recovered well from the transplant.

SourceThe Lancet·JournalThe Lancet HIV·DateMar 10, 2020

The Lancet Oncology: Targeted treatments for pancreatic cancer may help eligible patients live an extra year

Results from 46 patients who received targeted therapies alongside standard chemotherapy showed a 31-month average survival compared to 18 months for those without molecular changes. Targeted therapy has already improved survival for many forms of cancer and could be a game-changer for pancreatic cancer patients with specific alterations.

SourceThe Lancet·JournalThe Lancet Oncology·DateMar 2, 2020

The Lancet: World failing to provide children with a healthy life and a climate fit for their future: WHO-UNICEF-Lancet

A landmark report warns that every child worldwide faces existential threats from climate change and exploitative marketing practices, stalling progress in child and adolescent health over the past 20 years. The Global Index of 180 countries reveals no single country is adequately protecting children's health, environment, and futures.

SourceThe Lancet·JournalThe Lancet·DateFeb 18, 2020

The Lancet: Cervical cancer could be eliminated in countries worst affected by the disease, and 62 million women's lives could be saved by 2120

Two new studies quantify the potential for eliminating cervical cancer in 78 low-income and lower-middle income countries, proposing measures to avert 74 million cases and 62 million deaths over the next century. The proposed triple intervention strategy of HPV vaccination, cervical screening, and treatment could reduce mortality by up...

SourceThe Lancet·JournalThe Lancet·DateJan 30, 2020

The Lancet Planetary Health: Discriminatory redlining practices in the 1930s associated with present-day rates of emergency department visits due to asthma

Redlining practices in the 1930s are associated with higher rates of emergency department visits due to asthma, with a 39% increased risk in previously redlined neighbourhoods compared to non-redlined areas. Historical policies may have shaped neighbourhood development and air quality, contributing to asthma incidence.

SourceThe Lancet·JournalThe Lancet Planetary Health·DateJan 27, 2020

The Lancet Global Health: Guided self-help intervention reduces refugees' psychological distress and improves wellbeing in humanitarian crises

A guided self-help approach was safe and effective in reducing psychological distress and improving functioning among female South Sudanese refugee women living in Uganda. The intervention resulted in meaningful improvements in symptoms of depression, PTSD, and explosive anger, with benefits seen across different trauma histories and l...

SourceThe Lancet·JournalThe Lancet Global Health·DateJan 22, 2020

The Lancet Digital Health: Real-time flu prediction may be possible using wearable heart rate and sleep tracking devices

A study found improved real-time prediction of influenza-like illness in five US states compared to current surveillance methods using de-identified data from wearable devices. The researchers used Fitbit data to identify abnormal resting heart rates and sleep patterns, which were linked to increased risk of flu.

SourceThe Lancet·JournalThe Lancet Digital Health·DateJan 16, 2020

The Lancet Infectious Diseases: Scientists identify and characterise eight more deaths from Borna disease virus and suggest more cases could be identified

Researchers found genetic signs of Borna disease virus in brain tissue from patients with unknown cause of encephalitis, indicating a potential link to severe and deadly cases. The study suggests clinicians should test for BoDV-1 more often in patients with rapidly evolving central or peripheral nervous system disorders.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateJan 7, 2020

The Lancet Infectious Diseases: Scientists call for government action to control and treat unprecedented outbreak of childhood HIV in Pakistan

A recent study found that one in three children affected by the outbreak are yet to receive treatment, highlighting the need for urgent government intervention. The average age of children affected is just 3 years old, and most cases were transmitted through reused needles and contaminated blood products.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateDec 19, 2019